Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,457 JPY | -2.02% | -1.89% | -16.22% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
Sales 2024 * | 46.15B 294M | Sales 2025 * | 50.77B 324M | Capitalization | 35.42B 226M |
---|---|---|---|---|---|
Net income 2024 * | 5.83B 37.16M | Net income 2025 * | 3.86B 24.58M | EV / Sales 2024 * | 1.33 x |
Net Debt 2024 * | 25.86B 165M | Net Debt 2025 * | 24.69B 157M | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
6.08
x | P/E ratio 2025 * |
9.19
x | Employees | 1,621 |
Yield 2024 * |
2.92% | Yield 2025 * |
3.1% | Free-Float | 49.53% |
1 day | -2.02% | ||
1 week | -1.89% | ||
Current month | -1.89% | ||
1 month | -8.94% | ||
3 months | -14.09% | ||
6 months | -14.50% | ||
Current year | -16.22% |
Managers | Title | Age | Since |
---|---|---|---|
Takayuki Iwai
PSD | President | 60 | 06-11-30 |
Hirofumi Imai
CHM | Chairman | 60 | 87-03-31 |
Hiroshi Uji
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
BRD | Director/Board Member | 54 | 18-10-31 |
Keiji Hirai
BRD | Director/Board Member | 74 | 16-11-30 |
Director/Board Member | 71 | 17-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 14 M€ | +12.67% | ||
0.00% | 17 M€ | +16.94% | - | |
0.00% | 138,841 M€ | +17.70% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1,457 | -2.02% | 73,800 |
24-06-06 | 1,487 | +0.41% | 71,800 |
24-06-05 | 1,481 | -0.87% | 61,000 |
24-06-04 | 1,494 | -1.06% | 43,500 |
24-06-03 | 1,510 | +1.68% | 51,600 |
Delayed Quote Japan Exchange, June 07, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.22% | 232M | |
+45.82% | 754B | |
+40.95% | 630B | |
-6.16% | 352B | |
+19.86% | 331B | |
+9.32% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 4554 Stock